Thị Dùng, Nguyễn, Bùi Vinh Quang, and Nguyễn Văn Hiếu. “INITIAL OUTCOME OF USING PEMBROLIZUMB- A PD-1 RECEPTOR BLOKING ANTIBODY AS THE SECOND-LINE TREATMENT FOR PATIENTS WITH PRIMARY HEPATOCELLULAR CARCINOMA”. Vietnam Medical Journal 520, no. 1A (December 28, 2022). Accessed July 3, 2024. https://tapchiyhocvietnam.vn/index.php/vmj/article/view/3798.